Abstract
BackgroundAlthough new screening programmes with low‐dose computed tomography (LDCT) for lung cancer have been implemented throughout the United States, screening uptake remains low and screening‐eligible persons' decisions to screen or not remain poorly understood.ObjectiveTo describe how current and former long‐term smokers explain their decisions regarding participation in lung cancer screening.DesignPhone interviews using a semi‐structured interview guide were conducted to ask screening‐eligible persons to describe their decisions regarding screening with LDCT. The interviews were transcribed and analysed with conventional content analytic techniques.Setting and participantsA subsample of 40 participants (20 who had screened and 20 who had not) were drawn from the sample of a survey study whose participants were recruited by Facebook targeted advertisements.ResultsThe sample was divided into the following five groups based on their decisions regarding lung cancer screening participation: Group 1: no intention to be screened, Group 2: no deliberate consideration but somewhat open to being screened, Group 3: deliberate consideration but no definitive decision to be screened, Group 4: intention to be screened and Group 5: had been screened. Reasons for screening participation decisions are described for each group. Across groups, data revealed that screening‐eligible persons have a number of misconceptions regarding LDCT, including that a scan is needed only if one is symptomatic or has not had a chest x‐ray. A physician recommendation was a key influence on decisions to screen.Discussion and conclusionsEducation initiatives aimed at providers and long‐term smokers regarding LDCT is needed. Quality patient/provider communication is most likely to improve screening rates.
Highlights
Lung cancer screening with annual low‐dose computed tomography (LDCT) is recommended by the U
In 2013, the National Lung Screening Trial (NLST) results led to the Grade B recommendation from the US Preventive Services Task Force of lung cancer screening with low‐dose computed tomog‐ raphy (LDCT) for high‐risk individuals.[7]
As a result of the findings, the team determine that the groups identified in this analysis aligned with precaution adoption process model (PAPM)[15] and each group could be placed to be in one of the stages outlined in the model
Summary
Lung cancer screening with annual low‐dose computed tomography (LDCT) is recommended by the U. New screening programmes with low‐dose computed tomog‐ raphy (LDCT) for lung cancer have been implemented throughout the United States, screening uptake remains low and screening‐eligible persons' decisions to screen or not remain poorly understood. Objective: To describe how current and former long‐term smokers explain their deci‐ sions regarding participation in lung cancer screening. Data revealed that screening‐eligible persons have a number of misconceptions regarding LDCT, including that a scan is needed only if one is symptomatic or has not had a chest x‐ray. Quality patient/provider communication is most likely to improve screening rates
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
